Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.
Tundo S, Trefny M, Rodić A, Grueninger O, Brodmann N, Börsch A, Serger C, Fürst J, Buchi M, Buczak K, Müller AT, Sach-Peltason L, Don L, Herzig P, Lardinois D, Heinzelmann-Schwarz V, Mertz KD, Hojski A, Schaeuble K, Laubli H, Natoli M, Toso A, Luu TT, Zippelius A, Romagnani A. Tundo S, et al. Among authors: buczak k. J Immunother Cancer. 2024 Nov 17;12(11):e009860. doi: 10.1136/jitc-2024-009860. J Immunother Cancer. 2024. PMID: 39551607 Free PMC article.
DPM1 modulates desmosomal adhesion and epidermal differentiation through SERPINB5.
Rathod M, Franz H, Beyersdorfer V, Wanuske MT, Leal-Fischer K, Hanns P, Stüdle C, Zimmermann A, Buczak K, Schinner C, Spindler V. Rathod M, et al. Among authors: buczak k. J Cell Biol. 2024 Apr 1;223(4):e202305006. doi: 10.1083/jcb.202305006. Epub 2024 Mar 13. J Cell Biol. 2024. PMID: 38477878 Free PMC article.
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Codilupi T, Szybinski J, Arunasalam S, Jungius S, Dunbar AC, Stivala S, Brkic S, Albrecht C, Vokalova L, Yang JL, Buczak K, Ghosh N, Passweg JR, Rovo A, Angelillo-Scherrer A, Pankov D, Dirnhofer S, Levine RL, Koche R, Meyer SC. Codilupi T, et al. Among authors: buczak k. Clin Cancer Res. 2024 Feb 1;30(3):586-599. doi: 10.1158/1078-0432.CCR-23-0163. Clin Cancer Res. 2024. PMID: 37992313 Free PMC article.
Genetic validation of PfFKBP35 as an antimalarial drug target.
Thommen BT, Dziekan JM, Achcar F, Tjia S, Passecker A, Buczak K, Gumpp C, Schmidt A, Rottmann M, Grüring C, Marti M, Bozdech Z, Brancucci NMB. Thommen BT, et al. Among authors: buczak k. Elife. 2023 Nov 7;12:RP86975. doi: 10.7554/eLife.86975. Elife. 2023. PMID: 37934560 Free PMC article.
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer.
Auf der Maur P, Trefny MP, Baumann Z, Vulin M, Correia AL, Diepenbruck M, Kramer N, Volkmann K, Preca BT, Ramos P, Leroy C, Eichlisberger T, Buczak K, Zilli F, Okamoto R, Rad R, Jensen MR, Fritsch C, Zippelius A, Stadler MB, Bentires-Alj M. Auf der Maur P, et al. Among authors: buczak k. Cell Rep Med. 2023 Apr 18;4(4):101002. doi: 10.1016/j.xcrm.2023.101002. Epub 2023 Apr 11. Cell Rep Med. 2023. PMID: 37044095 Free PMC article.
31 results